Creating a versatile vaccine to take on COVID-19 in its many guises MIT frontiersin
Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, United StatesDepartment of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, United StatesDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Neuroscience, Cell Biology, and Anatomy, The University of Texas Medical Branch, Galveston, TX, United StatesNational...
Licensed COVID-19 vaccines ameliorate viral infection by inducing production of neutralizing antibodies that bind the SARS-CoV-2 Spike protein and inhibit viral cellular entry. However, the clinical effectiveness of these vaccines is transitory as viral variants escape antibody neutralization.
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Evaluating SARS-CoV-2 bivalent booster vaccine against severe COVID-19 outcomesIn a recent study posted to the medRxiv* preprint server, researchers assessed the effectiveness of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) bivalent booster vaccine against severe SARS-CoV-2 infection outcomes.
Read more »
ACE2: its diverse functions, relationship with SARS-CoV-2, and the implications for COVID-19 disease sequelaeACE2: its diverse functions, relationship with SARS-CoV-2, and the implications for COVID-19 disease sequelae CellCellPress UAlberta IMBA_Vienna ACE2 SARSCoV2 COVID19 coronavirus covid disease
Read more »
Are self-sanitizing disinfectants containing quaternary ammonium compounds truly effective against respiratory viruses?Researchers evaluated the antimicrobial efficiency of two commercially available disinfectants containing quaternary ammonium compounds against influenza A virus (hemagglutinin 1 neuraminidase 1 (H1N1)), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and human coronavirus 229E.
Read more »
Elucidation of the liver pathophysiology of COVID-19 patients using liver-on-a-chipsAbstract. SARS-CoV-2 induces severe organ damage not only in the lung but also in the liver, heart, kidney, and intestine. It is known that COVID-19 severity co
Read more »
A new class of drugs could prevent resistant COVID-19 variants, study findsThe constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered that a new class of oral drugs that acts directly on human cells can inhibit a diverse range of pathogenic SARS-CoV-2 strains.
Read more »